| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 97, 587-600, Copyright © 1979 by American Society for Investigative Pathology
REGULAR ARTICLES |
IR Hart
Several in vitro properties of two variant cell lines of the B16 melanoma (B16-F10 and B16-BL6) with markedly different spontaneous metastatic behavior were examined. The two cell lines were compared with regard to their in vitro growth rate, ability to migrate, ability to adhere to a variety of substrata, detachment rates, production of plasminogen activator, and cell surface proteins as determined by lactoperoxidase-catalyzed iodination. Growth rates in vitro, attachment rates, and qualitative patterns of cell surface proteins were almost identical. B16-F10 cells (the less spontaneously metastatic line) produced greater amounts of plasminogen activator, were more motile in vitro, and detached more readily from plastic than the more invasive B16-BL6 cells. The study of tumor cell variants, selected for different biologic behavior, is a valuable approach to the elucidation of those mechanisms responsible for their malignant activity.
This article has been cited by other articles:
 |
|
 |
|
  S. Darmanin, J. Chen, S. Zhao, H. Cui, R. Shirkoohi, N. Kubo, Y. Kuge, N. Tamaki, K. Nakagawa, J.-i. Hamada, et al. All-trans Retinoic Acid Enhances Murine Dendritic Cell Migration to Draining Lymph Nodes via the Balance of Matrix Metalloproteinases and Their Inhibitors J. Immunol., October 1, 2007; 179(7): 4616 - 4625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Langley and I. J. Fidler Tumor Cell-Organ Microenvironment Interactions in the Pathogenesis of Cancer Metastasis Endocr. Rev., May 1, 2007; 28(3): 297 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Yamazaki, T. Akada, O. Niizeki, T. Suzuki, H. Miyashita, and Y. Sato Puromycin-insensitive leucyl-specific aminopeptidase (PILSAP) binds and catalyzes PDK1, allowing VEGF-stimulated activation of S6K for endothelial cell proliferation and angiogenesis Blood, October 15, 2004; 104(8): 2345 - 2352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ito, N. Morita, D. Miura, Y.-i. Koma, T. R. Kataoka, H. Yamasaki, Y. Kitamura, Y. Kita, and H. Nojima A derivative of oleamide potently inhibits the spontaneous metastasis of mouse melanoma BL6 cells Carcinogenesis, October 1, 2004; 25(10): 2015 - 2022. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ito, Y.-i. Koma, M. Sohda, K. Watabe, T. Nagano, Y. Misumi, H. Nojima, and Y. Kitamura Localization of the PP2A B56{gamma} Regulatory Subunit at the Golgi Complex: Possible Role in Vesicle Transport and Migration Am. J. Pathol., February 1, 2003; 162(2): 479 - 489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Liu, H. Aaronson, D. J. Mitola, S. H. Leppla, and T. H. Bugge Potent antitumor activity of a urokinase-activated engineered anthrax toxin PNAS, January 21, 2003; 100(2): 657 - 662. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ito, Y.-i. Koma, K. Watabe, T. Nagano, Y. Endo, H. Nojima, and Y. Kitamura A Truncated Isoform of the Protein Phosphatase 2A B56{gamma} Regulatory Subunit May Promote Genetic Instability and Cause Tumor Progression Am. J. Pathol., January 1, 2003; 162(1): 81 - 91. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Staelens, B. Wielockx, L. Puimege, F. Van Roy, J.-L. Guenet, and C. Libert Hyporesponsiveness of SPRET/Ei mice to lethal shock induced by tumor necrosis factor and implications for a TNF-based antitumor therapy PNAS, July 9, 2002; 99(14): 9340 - 9345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kjaergaard, L. Peng, P. A. Cohen, J. A. Drazba, A. D. Weinberg, and S. Shu Augmentation Versus Inhibition: Effects of Conjunctional OX-40 Receptor Monoclonal Antibody and IL-2 Treatment on Adoptive Immunotherapy of Advanced Tumor J. Immunol., December 1, 2001; 167(11): 6669 - 6677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.'i Nakamoto, A. Ito, K. Watabe, Y.-i. Koma, H. Asada, K. Yoshikawa, Y. Shinomura, Y. Matsuzawa, H. Nojima, and Y. Kitamura Increased Expression of a Nucleolar Nop5/Sik Family Member in Metastatic Melanoma Cells : Evidence for Its Role in Nucleolar Sizing and Function Am. J. Pathol., October 1, 2001; 159(4): 1363 - 1374. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. P.M. Sutmuller, L. M. van Duivenvoorde, A. van Elsas, T. N.M. Schumacher, M. E. Wildenberg, J. P. Allison, R. E.M. Toes, R. Offringa, and C. J.M. Melief Synergism of Cytotoxic T Lymphocyte-associated Antigen 4 Blockade and Depletion of CD25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses J. Exp. Med., September 17, 2001; 194(6): 823 - 832. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Kim, B. J. Averbook, K. Chambers, K. Rothchild, J. Kjaergaard, R. Papay, and S. Shu Divergent Effects of 4-1BB Antibodies on Antitumor Immunity and on Tumor-reactive T-Cell Generation Cancer Res., March 1, 2001; 61(5): 2031 - 2037. [Abstract] [Full Text]
|
|
|
|
|
|
J. Kjærgaard, J. Tanaka, J. A. Kim, K. Rothchild, A. Weinberg, and S. Shu Therapeutic Efficacy of OX-40 Receptor Antibody Depends on Tumor Immunogenicity and Anatomic Site of Tumor Growth Cancer Res., October 1, 2000; 60(19): 5514 - 5521. [Abstract] [Full Text]
|
|
|
|
|
|
Q. Shi, Q. Xiong, B. Wang, X. Le, N. A. Khan, and K. Xie Influence of Nitric Oxide Synthase II Gene Disruption on Tumor Growth and Metastasis Cancer Res., May 1, 2000; 60(10): 2579 - 2583. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Li, X. Huang, Z. Zhu, and E. Gorelik Sequence and Insertion Sites of Murine Melanoma-Associated Retrovirus J. Virol., November 1, 1999; 73(11): 9178 - 9186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. van Elsas, A. A. Hurwitz, and J. P. Allison Combination Immunotherapy of B16 Melanoma Using Anti–Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4) and Granulocyte/Macrophage Colony-Stimulating Factor (GM-CSF)-producing Vaccines Induces Rejection of Subcutaneous and Metastatic Tumors Accompanied by Autoimmune Depigmentation J. Exp. Med., August 2, 1999; 190(3): 355 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. LaTemple, J. T. Abrams, S. Y. Zhang, and U. Galili Increased Immunogenicity of Tumor Vaccines Complexed with Anti-Gal: Studies in Knockout Mice for {{alpha}}1,3Galactosyltransferase Cancer Res., July 1, 1999; 59(14): 3417 - 3423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-M. Fu, Z.-X. Yu, B. A. Pelayo, V. J. Ferrans, and G. G. Meadows Focal Adhesion Kinase-dependent Apoptosis of Melanoma Induced by Tyrosine and Phenylalanine Deficiency Cancer Res., February 1, 1999; 59(3): 758 - 765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Takahashi, Z. Sheng, T. P. Horan, H. Kitayama, M. Maki, K. Hitomi, Y. Kitaura, S. Takai, R. M. Sasahara, A. Horimoto, et al. Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK PNAS, October 27, 1998; 95(22): 13221 - 13226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Komazawa, I. Saiki, Y. Igarashi, I. Azuma, M. Kojima, A. Orikasa, M. Ono, and I. Itoh Inhibition of Tumor Metastasis by a Synthetic Polymer Containing a Cell-Adhesive RGDS Peptide Journal of Bioactive and Compatible Polymers, January 1, 1993; 8(3): 258 - 274. [Abstract] [PDF]
|
|
|
|
 |
|
 M Nakajima, T Irimura, D Di Ferrante, N Di Ferrante, and G. Nicolson Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines Science, May 6, 1983; 220(4597): 611 - 613. [Abstract] [PDF]
|
|
|
|
|
|
I. Fidler and I. Hart Biological diversity in metastatic neoplasms: origins and implications Science, September 10, 1982; 217(4564): 998 - 1003. [Abstract] [PDF]
|
|
|
|
|
|
I. Fidler Therapy of spontaneous metastases by intravenous injection of liposomes containing lymphokines Science, June 27, 1980; 208(4451): 1469 - 1471. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
